27th Interphex Week 2025 Tokyo Exhibition

From the medical field to cosmetics and health food sectors, we provide optimal solutions with abundant experience and high engineering technology.

- Over 40 years of experience in the pharmaceutical factory construction field with more than 200 achievements - Leveraging the experience gained from specializing in user-oriented engineering, we support the establishment of optimal production facilities, from the development and production of pharmaceuticals to the maintenance of factories and equipment. <Pharmaceuticals> Active pharmaceutical ingredients, intermediates, formulations, injectables, biological products, nucleic acids, biopharmaceuticals, regenerative medicine <Cosmetics> Medicinal cosmetics, basic cosmetics, sun care, makeup, hair care cosmetics <Health Foods> Supplements, beverages, etc. For more details on Mitsubishi Chemical Engineering's medical engineering, please refer to the related links.

• Pharmaceutical factory equipment
• Pharmaceutical related factory equipment
• Plant Design

Streamlining the production of solid dosage forms and integrating factory functions into a one-stop system.

We will build an optimal continuous production system for our customers based on the continuous production process construction technology cultivated over many years through chemical plants and our extensive track record in the manufacturing of active pharmaceutical ingredients, cosmetics, and food. 【Features】 ■ Constructing an optimal continuous production system from the customer's perspective ■ Contributing to load reduction and achieving stable quality and stable supply through PSE & PAT ■ The inspection and sorting device "iSorter," which supports the development of quality control strategies, can automatically sort off-spec products ■ Planning a quality control strategy suitable for the manufacturing process and building an optimal information control system 【Benefits of Implementing Continuous Production (Examples)】 ■ Stable quality supply ・ Real-time monitoring enables reliable manufacturing ■ Flexibility in production volume ・ Adjusting production volume by changing operating hours ・ Flexibly responding to fluctuations in demand ■ Space-saving manufacturing equipment ・ Reduction and space-saving of equipment ・ Reduction in energy consumption

• Other production management systems
• Other pharmaceutical factory equipment and parts
• Pharmaceutical related factory equipment

Containment systems in the production of highly pharmacologically active substances.

In recent years, the expansion of the market for anticancer drugs and other pharmaceuticals has led to an increase in manufacturing facilities for highly pharmacologically active drugs. In such manufacturing facilities, containment technologies are required to prevent the dispersion and suspension of highly pharmacologically active powders in response to cross-contamination, health hazards, and environmental pollution. Our company will build the optimal containment system tailored to the grade of containment required for manufacturing facilities. 【Features】 ■ Ensures a reliable level of safety and health management for workers through exposure management ■ Guarantees product quality by preventing cross-contamination ■ Optimal system based on equipment shape and workability ■ Comprehensive construction of the entire manufacturing facility, including primary and secondary containment 【Examples of containment equipment using isolators (primary containment)】 ■ Charging into the reactor ■ Extraction from the filter dryer ■ Extraction from the filter

• Other pharmaceutical factory equipment and parts
• Other pharmaceutical-related factory equipment and parts
• Pharmaceutical related factory equipment

Gather, know, and lead to the future! A partner for stabilizing quality that realizes "productivity improvement" and "strengthening on-site capabilities."

"VectorScope" visualizes various manufacturing-related data accumulated in the production site, such as temperature, pressure, and raw material composition, using a unique synthetic vector method to create a new indicator called "manufacturing status." By exploring the relationship between this manufacturing status and product quality, we aim to achieve "productivity improvement" and "skill enhancement of technical staff" in collaboration with our customers, contributing to further stable growth through "DX." This method has a proven track record across various fields and processes, from chemicals and resins to pharmaceuticals and food. [Features] - Anyone can engage in big data analysis without knowledge of statistical analysis. - Visualization of manufacturing experience enables understanding and sharing of the manufacturing site's capabilities (Best Practices). - Deepening, inheriting, and expanding technology through a spiral-up of manufacturing improvements. - Achieving productivity improvement in your factory through "visualization of manufacturing experience." - Realizing speedy and effective continuous manufacturing quality improvement activities. [Commitment to DX] - Transitioning to data-driven on-site communication. - Deepening manufacturing technology and inheriting skills using manufacturing performance data. - Early detection and improvement of issues through continuous visualization of manufacturing data.

• Other analyses
• Production Management System
• Business Intelligence and Data Analysis

In spatial biology/spatial proteomics research, the coexistence of "high-quality multiplex fluorescence image acquisition" and "reliable quantitative analysis" is becoming increasingly important. This webinar, co-hosted by Thermo Fisher Scientific and Indica Labs, will introduce a practical workflow that allows for a comprehensive understanding from imaging to analysis. Recommended for: - Those interested in spatial biology/spatial proteomics research who want to systematically understand the entire process from imaging to analysis. - Those who are already conducting or considering the implementation of multiplex imaging (multiplex immunostaining). - Those who feel limited by traditional four-color fluorescence observation and wish to engage in higher-dimensional spatial information analysis. This is a free seminar, so please join us. *For research use only. Not for diagnostic use.

Cancer Biomarker Discovery 2026 is an online seminar focused on the latest biomarker discovery and analysis technologies in the field of cancer research. Advanced technologies that support the understanding, diagnosis, and treatment research of cancer, such as liquid biopsy, proteomics, and spatial omics analysis, will be introduced. This seminar primarily targets basic and clinical researchers involved in cancer research, as well as those interested in biomarker discovery and analysis. In our section, we will introduce the latest techniques in fluorescent imaging for spatial biology and spatial proteomics research, centered around the Invitrogen EVOS S1000 Spatial Imaging System. Unlike traditional microscopy, which is limited in multiplex immunostaining, our spectral unmixing technology enables simultaneous imaging of up to 9 colors, allowing for rapid data acquisition with minimized sample damage. Additionally, we will explain a practical workflow using direct conjugate antibodies and TSA-based Invitrogen Aluora amplification reagents, proposing high-reproducibility analysis methods that leverage spatial information. For research use only. Not for diagnostic use.

[Speaker] Shinya Okimoto, Founder & CEO of Okiwa Studio LLC [Lecture Topics] Part 1: The tectonic shifts in the display industry and the market potential of QDEL Part 2: Business solutions to the "three major technical challenges" for the practical application of QDEL Part 3: Winning strategies for Japanese companies: Targeting the "high value-added components" sector Part 4: Redefining the business portfolio towards 2030 Part 5: Q&A

[Lecturer] Mr. Kenji Kimura, Chief Researcher, Nuclear Group, Power Unit, Japan Energy Economics Research Institute (JEA), and Research Strategy Group, Research Strategy Unit [Key Lecture Content] In recent years, the role of nuclear power has been highlighted in the context of global warming countermeasures and energy security, and more recently, in response to the increased electricity demand due to the use of AI and the expansion of data centers. Under these circumstances, new movements are being observed in countries that utilize nuclear power. In the United States, investments in nuclear power by IT companies are becoming more active, while in Europe, measures are being promoted to enhance the feasibility of new projects. In Japan, the role of nuclear power has been clarified once again, and discussions surrounding specific institutional measures are gradually progressing. This lecture will provide an overview of these movements and organize the trends that should be noted in the future. [Lecture Items] 1. Global Situation and Nuclear Power 2. Trends in Other Countries 3. Trends in New Reactor Development 4. Domestic Trends and Challenges 5. Key Points to Watch After 2026 6. Q&A / Business Card Exchange

At our booth, we will mainly showcase the following products: 〇 Our original product T-Arm 〇 Tecnospiro's product Spider 〇 Knight Global's product Air Balancer 〇 A drone for equipment inspections ▽------------------------------------------------------------▽ From April 8 (Wednesday) to April 10 (Friday) at Port Messe Nagoya ■ Manufacturing World Nagoya (Booth Number: 16-40) https://www.manufacturing-world.jp/nagoya/ja-jp.html ■ Pre-registration for attendance is convenient! https://www.manufacturing-world.jp/nagoya/ja-jp/register.html?code=1603005193330205-52G △------------------------------------------------------------△ We look forward to your visit.